<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02456025</url>
  </required_header>
  <id_info>
    <org_study_id>TEC 124</org_study_id>
    <nct_id>NCT02456025</nct_id>
  </id_info>
  <brief_title>Topical Tacrolimus in Vernal Keratoconjunctivitis</brief_title>
  <official_title>Topical Tacrolimus in Vernal Keratoconjunctivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Eye Center and The Eye Foundation for Research in Ophthalmology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Eye Center and The Eye Foundation for Research in Ophthalmology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this study is to evaluate the efficacy and safety of topical tacrolimus 0.01%
      eyedrops in patients with vernal keratoconjunctivitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 20 patients with bilateral symmetrical vernal keratoconjunctivitis will be
      included. Each patient will undergo a complete ophthalmologic evaluation. Patient will be
      placed at random on topical Tacrolimus 0.01% ophthalmic solution in one eye and placebo
      eyedrops in the fellow eye. Patients will undergo ophthalmologic examination at one week and
      after one month. Photos will be taken. The outcome measures include graded symptoms, graded
      signs, and laboratory investigations. Symptoms of itching, redness, foreign body sensation,
      tearing and discharge following will be recorded before and after treatment. The grading of
      clinical signs of conjunctival hyperemia, conjunctival papillary hypertrophy, perilimbal
      infiltrates, Trantas dots, superficial punctate keratopathy will be recorded before and after
      treatment. Conjunctival surface temperature will be determined before and after treatment.
      Conjunctival scrapings will be stained with Giemsa and will be assessed before and after
      therapy and number of eosinophils per hpf will be determined and recorded.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The efficacy of Topical Tacrolimus in Vernal Keratoconjunctivitis</measure>
    <time_frame>Five months</time_frame>
    <description>To evaluate the efficacy of topical tacrolimus 0.01 eye drops in patients with vernal keratoconjunctivitis in symptoms of redness, itching, foreign body sensation and discharge and signs of conjunctival hyperemia,perlimbal infiltrates, Trantas dots and papillary reaction</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Vernal Keratoconjunctivitis</condition>
  <arm_group>
    <arm_group_label>Topical tacrolimus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 eyes with active Vernal Keratoconjunctivitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 eyes with active Vernal Keratoconjunctivitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical tacrolimus</intervention_name>
    <description>Topical tacrolimus 0.01% twice daily for one month</description>
    <arm_group_label>Topical tacrolimus</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Tacrolimus eye drops</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  with bilateral symmetrical palpebral and limbal vernal keratoconjunctivitis

          -  Patients 6-18 years of age

        Exclusion Criteria:

          -  Pregnant patients

          -  Patients on systemic therapy for other allergic disorders

          -  Patients who cannot come for follow-up

          -  Patients who are on other topical medications for other comorbid ocular conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samir S Shoughy</last_name>
    <role>Principal Investigator</role>
    <affiliation>THE EYE CENTER</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samir S Shoughy</last_name>
    <phone>0096614649614</phone>
    <email>samir.shawki@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Khalid F Tabbara</last_name>
    <phone>0096614649614</phone>
    <email>k.tabbara@nesma.net.sa</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Eye Center</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir S Shoughy</last_name>
      <phone>0096614649614</phone>
      <email>samir.shawki@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Khalid F Tabbara</last_name>
      <phone>0096614649614</phone>
      <email>k.tabbara@nesma.net.sa</email>
    </contact_backup>
    <investigator>
      <last_name>Samir S Shoughy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2013</study_first_submitted>
  <study_first_submitted_qc>May 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>November 22, 2015</last_update_submitted>
  <last_update_submitted_qc>November 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Eye Center and The Eye Foundation for Research in Ophthalmology</investigator_affiliation>
    <investigator_full_name>Samir S. Shoughy, MD, FRCS (Glasg.)</investigator_full_name>
    <investigator_title>Ophthalmologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

